# Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

> **NCT00434213** · PHASE4 · COMPLETED · sponsor: **Noven Therapeutics** · enrollment: 309 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Daytrana

## Key facts

- **NCT ID:** NCT00434213
- **Lead sponsor:** Noven Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-08
- **Final completion:** 2008-07
- **Target enrollment:** 309 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00434213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00434213, "Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00434213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*